| Wojciech C Janowski, MD | |
|
5957 Fashion Point Dr Ste 103, South Ogden, UT 84403-5180 | |
| (385) 492-4930 | |
| (385) 492-4449 |
| Full Name | Wojciech C Janowski |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 21 Years |
| Location | 5957 Fashion Point Dr Ste 103, South Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316150477 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portneuf Medical Center | Pocatello, ID | Hospital |
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
| Pocatello Health Services Llc | 6608927637 | 136 |
News Archive
A new study examines how SARS-CoV-2 variants confer a competitive advantage on the virus, fueling further transmission and mortality.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
Why does exposure to rhythmic stimulation at certain frequencies facilitate the occurrence of epileptic seizures? In 1997, flickering patterns in an episode of the series Pokémon triggered epileptic seizures in nearly 700 Japanese children.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
A new study examines how SARS-CoV-2 variants confer a competitive advantage on the virus, fueling further transmission and mortality.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
Why does exposure to rhythmic stimulation at certain frequencies facilitate the occurrence of epileptic seizures? In 1997, flickering patterns in an episode of the series Pokémon triggered epileptic seizures in nearly 700 Japanese children.
› Verified 5 days ago
| Entity Name | Ogden Pulmonary Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457596801 PECOS PAC ID: 3678638517 Enrollment ID: O20090210000370 |
News Archive
A new study examines how SARS-CoV-2 variants confer a competitive advantage on the virus, fueling further transmission and mortality.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
Why does exposure to rhythmic stimulation at certain frequencies facilitate the occurrence of epileptic seizures? In 1997, flickering patterns in an episode of the series Pokémon triggered epileptic seizures in nearly 700 Japanese children.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wojciech C Janowski, MD Po Box 150627, Ogden, UT 84415-0627 Ph: (385) 492-4930 | Wojciech C Janowski, MD 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403-5180 Ph: (385) 492-4930 |
News Archive
A new study examines how SARS-CoV-2 variants confer a competitive advantage on the virus, fueling further transmission and mortality.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
Why does exposure to rhythmic stimulation at certain frequencies facilitate the occurrence of epileptic seizures? In 1997, flickering patterns in an episode of the series Pokémon triggered epileptic seizures in nearly 700 Japanese children.
› Verified 5 days ago
Dr. Charles Thomas Ivester, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Robert Cheney, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 801-807-7597 | |
Christopher K Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Mohammad Omer Syed, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Dr. Gaurav Dagar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Terrence Wayne Andrews, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 |